pharmaceutical industry

Company headquarters are now based in Ireland

Deal is to be completed in the first quarter of 2015

The company offered no comment on a report in an Israeli business publication

Zabriske led Upjohn in the mid-1990's and is considered the architect of the merger with Swedish drug giant Pharmacia AB

The products are expected to generate at least $20-million in annual revenue